Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy

Haematologica. 2018 Nov;103(11):e527-e530. doi: 10.3324/haematol.2018.195453. Epub 2018 Jun 7.

Authors

Anne-Sophie Brunel¹, Agnieszka Wójtowicz¹, Frédéric Lamoth^{1

2}, Olivier Spertini³, Dionysios Neofytos⁴, Thierry Calandra¹, Oscar Marchetti^{1

5}, Pierre-Yves Bochud⁶

Affiliations

¹ Infectious Diseases Service, Department of Medicine, Lausanne University Hospital (CHUV).
² Microbiology Institute, Lausanne University Hospital (CHUV).
³ Hematology Service, Department of Oncology, Lausanne University Hospital (CHUV).
⁴ Infectious Diseases Service, University Hospital Geneva (HUG).
⁵ Department of Medicine, Ensemble Hospitalier de la Côte, Morges, Switzerland.
⁶ Infectious Diseases Service, Department of Medicine, Lausanne University Hospital (CHUV) Pierre-Yves.Bochud@chuv.ch.

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Adult
Anemia, Refractory, with Excess of Blasts* / drug therapy
Anemia, Refractory, with Excess of Blasts* / genetics
Anemia, Refractory, with Excess of Blasts* / microbiology
Aspergillosis / chemically induced
Aspergillosis / genetics*
C-Reactive Protein / genetics*
Female
Humans
Leukemia, Myeloid, Acute* / drug therapy
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / microbiology
Male
Neoplasm Proteins / genetics*
Polymorphism, Single Nucleotide*
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / microbiology
Serum Amyloid P-Component / genetics*

Substances

Neoplasm Proteins
Serum Amyloid P-Component
PTX3 protein
C-Reactive Protein